The Align Technology Inc (ALGN) share price is expected to increase by 17.16% over the next year. This is based on calculating the average 12-month share price estimate provided by 11 stock analysts who have covered ALGN. Price targets range from $200 at the low end to $320 at the high end. The current analyst consensus for ALGN is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
About 11 Wall Street analysts have assignedALGN 11 buy ratings, 0 hold ratings, and 0 sell ratings. This means that analysts expect Align Technology Inc to buy. Keep in mind that these ratings are typically refreshed every quarter, underscoring the importance of conducting your own research on ALGN. Don't forget to include both technical and fundamental analysis, as well as staying informed on news that could influence these ratings, in your due diligence.
These are the latest 20 analyst ratings of ALGN.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
David Saxon Needham | Hold | Reiterates | Nov 4, 2024 | |
Elizabeth Anderson Evercore ISI Group | Outperform | $250 | Maintains | Oct 24, 2024 |
Erin Wright Morgan Stanley | Overweight | $280 | Maintains | Oct 24, 2024 |
Jonathan Block Stifel | Buy | $275 | Maintains | Oct 24, 2024 |
David Saxon Needham | Hold | Reiterates | Oct 24, 2024 | |
Jason Bednar Piper Sandler | Overweight | $275 | Maintains | Oct 24, 2024 |
Jeff Johnson Baird | Outperform | $276 | Maintains | Oct 24, 2024 |
Jason Bednar Piper Sandler | Overweight | $285 | Maintains | Oct 17, 2024 |
Jonathan Block Stifel | Buy | $285 | Maintains | Oct 11, 2024 |
David Saxon Needham | Hold | Initiates | Oct 10, 2024 | |
Elizabeth Anderson Evercore ISI Group | Outperform | $270 | Maintains | Oct 8, 2024 |
Jason Bednar Piper Sandler | Overweight | $315 | Maintains | Sep 13, 2024 |
Erin Wright Morgan Stanley | Overweight | $310 | Maintains | Jul 25, 2024 |
Jason Bednar Piper Sandler | Overweight | $315 | Maintains | Jul 25, 2024 |
Jonathan Block Stifel | Buy | $350 | Maintains | Jul 25, 2024 |
Jeff Johnson Baird | Outperform | $325 | Maintains | Jul 22, 2024 |
Jason Bednar Piper Sandler | Overweight | $330 | Maintains | Jul 10, 2024 |
Jason Bednar Piper Sandler | Overweight | $330 | Maintains | Jun 21, 2024 |
Elizabeth Anderson Evercore ISI Group | Outperform | $300 | Maintains | Jun 10, 2024 |
OTR Global | Mixed | Downgrade | Jun 4, 2024 |
When did it IPO
2001
Staff Count
21,805
Country
United States
Sector/Industry
Healthcare/Medical Instruments & Supplies
CEO
Mr. Joseph M. Hogan
Market Cap
$16.46B
In 2023, ALGN generated $3.86B in revenue, which was a increase of 3.42% from the previous year. This can be seen as a signal that ALGN's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Align Technology, Inc. (NASDAQ: ALGN) has launched its 2025 Annual Research Award Program, offering up to $300,000 for dental research initiatives, totaling $3.75 million funded historically.
Why It Matters - Align Technology's funding for dental research enhances its brand reputation and innovation pipeline, potentially leading to improved products and increased market share, positively impacting stock performance.
Summary - Align Technology, Inc. (Nasdaq: ALGN) will present at upcoming financial conferences, with live webcasts available via their Investor Relations section.
Why It Matters - Align Technology's participation in financial conferences highlights its commitment to transparency and investor engagement, potentially influencing investor sentiment and stock performance.
Summary - Super Micro's stock fell 33% on Wednesday, leading to its addition to a specific list of companies affected by significant price drops.
Why It Matters - A 33% drop in Super Micro's stock signals potential volatility and may indicate underlying issues, affecting investor sentiment and market confidence.
Summary - Align Technology's Q3 earnings showed EPS at $2.35, beating estimates, but revenue missed at $977.87M. The company expects 5.29%-7.53% revenue growth from Q4 2024 to Q4 2026.
Why It Matters - Align Technology's mixed Q3 earnings indicate strong EPS performance but revenue challenges. Growth in international markets and product enhancements signal resilience and potential long-term value.
Summary - Align Technology has launched Invisalign Smile Architect software, offering Multiple Treatment Plans for personalized orthodontic care.
Why It Matters - Align Technology's launch of Invisalign Smile Architect enhances competitive positioning and potential revenue growth through personalized treatment options, signaling innovation and market expansion.
Summary - Align Technology reported third-quarter revenue below Wall Street estimates due to lower demand for clear teeth aligners among younger patients.
Why It Matters - Align Technology's missed revenue estimates indicate weakening demand, suggesting potential challenges in growth and profitability, which may negatively impact stock performance and investor confidence.